nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0269	0.282	CbGbCtD
Oxazepam—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.0208	0.0486	CcSEcCtD
Oxazepam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0182	0.19	CbGbCtD
Oxazepam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0174	0.182	CbGbCtD
Oxazepam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0155	0.162	CbGbCtD
Oxazepam—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.015	0.0349	CcSEcCtD
Oxazepam—Memory impairment—Montelukast—chronic obstructive pulmonary disease	0.00971	0.0226	CcSEcCtD
Oxazepam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00908	0.0949	CbGbCtD
Oxazepam—Aggression—Montelukast—chronic obstructive pulmonary disease	0.00867	0.0202	CcSEcCtD
Oxazepam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00857	0.0897	CbGbCtD
Oxazepam—Aggression—Salbutamol—chronic obstructive pulmonary disease	0.00836	0.0195	CcSEcCtD
Oxazepam—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.00829	0.0193	CcSEcCtD
Oxazepam—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.00761	0.0177	CcSEcCtD
Oxazepam—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00631	0.0147	CcSEcCtD
Oxazepam—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00628	0.0146	CcSEcCtD
Oxazepam—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00618	0.0144	CcSEcCtD
Oxazepam—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00602	0.014	CcSEcCtD
Oxazepam—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.00553	0.0129	CcSEcCtD
Oxazepam—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00501	0.0117	CcSEcCtD
Oxazepam—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00447	0.0104	CcSEcCtD
Oxazepam—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00432	0.0101	CcSEcCtD
Oxazepam—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00426	0.00993	CcSEcCtD
Oxazepam—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00419	0.00976	CcSEcCtD
Oxazepam—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00415	0.00968	CcSEcCtD
Oxazepam—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00411	0.00958	CcSEcCtD
Oxazepam—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00411	0.00957	CcSEcCtD
Oxazepam—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00403	0.00939	CcSEcCtD
Oxazepam—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.004	0.00933	CcSEcCtD
Oxazepam—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00397	0.00926	CcSEcCtD
Oxazepam—Memory impairment—Prednisone—chronic obstructive pulmonary disease	0.0039	0.00909	CcSEcCtD
Oxazepam—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00381	0.00887	CcSEcCtD
Oxazepam—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00378	0.00881	CcSEcCtD
Oxazepam—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.0037	0.00863	CcSEcCtD
Oxazepam—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00362	0.00844	CcSEcCtD
Oxazepam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00362	0.00843	CcSEcCtD
Oxazepam—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00359	0.00836	CcSEcCtD
Oxazepam—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00345	0.00804	CcSEcCtD
Oxazepam—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00344	0.00803	CcSEcCtD
Oxazepam—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00344	0.00801	CcSEcCtD
Oxazepam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00343	0.00798	CcSEcCtD
Oxazepam—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00341	0.00794	CcSEcCtD
Oxazepam—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00338	0.00789	CcSEcCtD
Oxazepam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00325	0.00757	CcSEcCtD
Oxazepam—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00319	0.00743	CcSEcCtD
Oxazepam—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00319	0.00743	CcSEcCtD
Oxazepam—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00312	0.00728	CcSEcCtD
Oxazepam—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00312	0.00728	CcSEcCtD
Oxazepam—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00312	0.00727	CcSEcCtD
Oxazepam—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00309	0.0072	CcSEcCtD
Oxazepam—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00306	0.00713	CcSEcCtD
Oxazepam—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00301	0.00701	CcSEcCtD
Oxazepam—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00298	0.00695	CcSEcCtD
Oxazepam—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00295	0.00688	CcSEcCtD
Oxazepam—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00288	0.00672	CcSEcCtD
Oxazepam—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00288	0.00672	CcSEcCtD
Oxazepam—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00288	0.00672	CcSEcCtD
Oxazepam—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00288	0.00671	CcSEcCtD
Oxazepam—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00282	0.00658	CcSEcCtD
Oxazepam—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00281	0.00655	CcSEcCtD
Oxazepam—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00278	0.00647	CcSEcCtD
Oxazepam—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00278	0.00647	CcSEcCtD
Oxazepam—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00272	0.00634	CcSEcCtD
Oxazepam—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00272	0.00634	CcSEcCtD
Oxazepam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00269	0.00626	CcSEcCtD
Oxazepam—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00263	0.00613	CcSEcCtD
Oxazepam—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00262	0.00611	CcSEcCtD
Oxazepam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00259	0.00604	CcSEcCtD
Oxazepam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00259	0.00604	CcSEcCtD
Oxazepam—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00601	CcSEcCtD
Oxazepam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00253	0.0059	CcSEcCtD
Oxazepam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00247	0.00575	CcSEcCtD
Oxazepam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00247	0.00575	CcSEcCtD
Oxazepam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00245	0.00571	CcSEcCtD
Oxazepam—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00244	0.00569	CcSEcCtD
Oxazepam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00242	0.00563	CcSEcCtD
Oxazepam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00241	0.00562	CcSEcCtD
Oxazepam—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00237	0.00551	CcSEcCtD
Oxazepam—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00548	CcSEcCtD
Oxazepam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00233	0.00543	CcSEcCtD
Oxazepam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0023	0.00536	CcSEcCtD
Oxazepam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0023	0.00535	CcSEcCtD
Oxazepam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00228	0.00532	CcSEcCtD
Oxazepam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00227	0.0053	CcSEcCtD
Oxazepam—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00227	0.00529	CcSEcCtD
Oxazepam—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00227	0.00529	CcSEcCtD
Oxazepam—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00227	0.00529	CcSEcCtD
Oxazepam—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00222	0.00518	CcSEcCtD
Oxazepam—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.00511	CcSEcCtD
Oxazepam—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.00511	CcSEcCtD
Oxazepam—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00219	0.00511	CcSEcCtD
Oxazepam—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00219	0.00511	CcSEcCtD
Oxazepam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00217	0.00505	CcSEcCtD
Oxazepam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00217	0.00505	CcSEcCtD
Oxazepam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00217	0.00505	CcSEcCtD
Oxazepam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00215	0.00502	CcSEcCtD
Oxazepam—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00501	CcSEcCtD
Oxazepam—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00501	CcSEcCtD
Oxazepam—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00214	0.00499	CcSEcCtD
Oxazepam—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00483	CcSEcCtD
Oxazepam—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00483	CcSEcCtD
Oxazepam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00477	CcSEcCtD
Oxazepam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00477	CcSEcCtD
Oxazepam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00204	0.00476	CcSEcCtD
Oxazepam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.002	0.00467	CcSEcCtD
Oxazepam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.0045	CcSEcCtD
Oxazepam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00428	CcSEcCtD
Oxazepam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00428	CcSEcCtD
Oxazepam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0018	0.00419	CcSEcCtD
Oxazepam—Rash—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00408	CcSEcCtD
Oxazepam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00408	CcSEcCtD
Oxazepam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00407	CcSEcCtD
Oxazepam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00407	CcSEcCtD
Oxazepam—Bromazepam—CYP1A2—chronic obstructive pulmonary disease	0.00174	0.179	CrCbGaD
Oxazepam—Headache—Formoterol—chronic obstructive pulmonary disease	0.00174	0.00405	CcSEcCtD
Oxazepam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00174	0.00405	CcSEcCtD
Oxazepam—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00174	0.00405	CcSEcCtD
Oxazepam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00404	CcSEcCtD
Oxazepam—Rash—Montelukast—chronic obstructive pulmonary disease	0.00171	0.00399	CcSEcCtD
Oxazepam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00171	0.00399	CcSEcCtD
Oxazepam—Headache—Montelukast—chronic obstructive pulmonary disease	0.0017	0.00397	CcSEcCtD
Oxazepam—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00165	0.00386	CcSEcCtD
Oxazepam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00385	CcSEcCtD
Oxazepam—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00165	0.00385	CcSEcCtD
Oxazepam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00385	CcSEcCtD
Oxazepam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00384	CcSEcCtD
Oxazepam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00384	CcSEcCtD
Oxazepam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00383	CcSEcCtD
Oxazepam—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00162	0.00377	CcSEcCtD
Oxazepam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00161	0.00376	CcSEcCtD
Oxazepam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00363	CcSEcCtD
Oxazepam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00356	CcSEcCtD
Oxazepam—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.0015	0.0035	CcSEcCtD
Oxazepam—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00148	0.00345	CcSEcCtD
Oxazepam—Amoxapine—SLC6A4—chronic obstructive pulmonary disease	0.00138	0.142	CrCbGaD
Oxazepam—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00135	0.00315	CcSEcCtD
Oxazepam—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00294	CcSEcCtD
Oxazepam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00287	CcSEcCtD
Oxazepam—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.0012	0.0028	CcSEcCtD
Oxazepam—Syncope—Prednisone—chronic obstructive pulmonary disease	0.0012	0.0028	CcSEcCtD
Oxazepam—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00274	CcSEcCtD
Oxazepam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00258	CcSEcCtD
Oxazepam—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00255	CcSEcCtD
Oxazepam—Shock—Prednisone—chronic obstructive pulmonary disease	0.00107	0.0025	CcSEcCtD
Oxazepam—Amoxapine—HTR2A—chronic obstructive pulmonary disease	0.00106	0.109	CrCbGaD
Oxazepam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000994	0.00232	CcSEcCtD
Oxazepam—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000981	0.00229	CcSEcCtD
Oxazepam—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000948	0.00221	CcSEcCtD
Oxazepam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000947	0.00221	CcSEcCtD
Oxazepam—Clonazepam—ALB—chronic obstructive pulmonary disease	0.000943	0.0971	CrCbGaD
Oxazepam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000942	0.00219	CcSEcCtD
Oxazepam—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000893	0.00208	CcSEcCtD
Oxazepam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000893	0.00208	CcSEcCtD
Oxazepam—Flurbiprofen—ALB—chronic obstructive pulmonary disease	0.000885	0.0911	CrCbGaD
Oxazepam—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000863	0.00201	CcSEcCtD
Oxazepam—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000863	0.00201	CcSEcCtD
Oxazepam—Clozapine—CYP1A1—chronic obstructive pulmonary disease	0.000856	0.0881	CrCbGaD
Oxazepam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.000836	0.0861	CrCbGaD
Oxazepam—Clozapine—CYP1A2—chronic obstructive pulmonary disease	0.000825	0.085	CrCbGaD
Oxazepam—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000824	0.00177	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000824	0.00177	CbGpPWpGaD
Oxazepam—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00082	0.00176	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000812	0.00174	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000811	0.00174	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000808	0.00174	CbGpPWpGaD
Oxazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000808	0.00173	CbGpPWpGaD
Oxazepam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000805	0.00188	CcSEcCtD
Oxazepam—UGT1A9—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000798	0.00171	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000796	0.00171	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000796	0.00171	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000782	0.00168	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000777	0.00167	CbGpPWpGaD
Oxazepam—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000775	0.00167	CbGpPWpGaD
Oxazepam—UGT1A9—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000771	0.00166	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000763	0.00164	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000756	0.00162	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000753	0.00162	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000744	0.0016	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000742	0.00159	CbGpPWpGaD
Oxazepam—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000735	0.00158	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000734	0.00158	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000724	0.00155	CbGpPWpGaD
Oxazepam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000722	0.00168	CcSEcCtD
Oxazepam—CYP3A43—Metabolism—APIP—chronic obstructive pulmonary disease	0.000718	0.00154	CbGpPWpGaD
Oxazepam—UGT2B7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000714	0.00153	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000713	0.00153	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00071	0.00152	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000708	0.00152	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.0007	0.0015	CbGpPWpGaD
Oxazepam—Clozapine—HTR2A—chronic obstructive pulmonary disease	0.000696	0.0717	CrCbGaD
Oxazepam—Rash—Prednisone—chronic obstructive pulmonary disease	0.000689	0.00161	CcSEcCtD
Oxazepam—UGT2B7—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000688	0.00148	CbGpPWpGaD
Oxazepam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000688	0.0016	CcSEcCtD
Oxazepam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000684	0.00159	CcSEcCtD
Oxazepam—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00068	0.00146	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000679	0.00146	CbGpPWpGaD
Oxazepam—UGT2B7—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000679	0.00146	CbGpPWpGaD
Oxazepam—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000677	0.00145	CbGpPWpGaD
Oxazepam—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000676	0.00145	CbGpPWpGaD
Oxazepam—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000673	0.00145	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000667	0.00143	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000661	0.00142	CbGpPWpGaD
Oxazepam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00065	0.0014	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000649	0.00139	CbGpPWpGaD
Oxazepam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000649	0.00151	CcSEcCtD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000643	0.00138	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000638	0.00137	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000633	0.00136	CbGpPWpGaD
Oxazepam—UGT2B7—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000633	0.00136	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000622	0.00134	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000616	0.00132	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000616	0.00132	CbGpPWpGaD
Oxazepam—UGT1A9—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000611	0.00131	CbGpPWpGaD
Oxazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000608	0.00131	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000604	0.0013	CbGpPWpGaD
Oxazepam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000604	0.0013	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GC—chronic obstructive pulmonary disease	0.000599	0.00129	CbGpPWpGaD
Oxazepam—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000598	0.00128	CbGpPWpGaD
Oxazepam—UGT2B7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000596	0.00128	CbGpPWpGaD
Oxazepam—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000596	0.00128	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000595	0.00128	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000589	0.00126	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000588	0.00126	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00058	0.00125	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000559	0.0012	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000557	0.0012	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000555	0.00119	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000552	0.00118	CbGpPWpGaD
Oxazepam—UGT2B7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000547	0.00118	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000544	0.00117	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000528	0.00113	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000526	0.00113	CbGpPWpGaD
Oxazepam—UGT2B7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000519	0.00111	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000518	0.00111	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000514	0.0011	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000498	0.00107	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000495	0.00106	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000493	0.00106	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000491	0.00105	CbGpPWpGaD
Oxazepam—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000489	0.00105	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000488	0.00105	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000484	0.00104	CbGpPWpGaD
Oxazepam—Diazepam—ALB—chronic obstructive pulmonary disease	0.000483	0.0497	CrCbGaD
Oxazepam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000478	0.00103	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000476	0.00102	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GC—chronic obstructive pulmonary disease	0.000463	0.000994	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000451	0.000968	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000446	0.000958	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000445	0.000955	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00043	0.000924	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00043	0.000924	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000427	0.000918	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000425	0.000914	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000423	0.000909	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000422	0.000905	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000413	0.000886	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000412	0.000885	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000407	0.000874	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000395	0.000848	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000395	0.000848	CbGpPWpGaD
Oxazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000386	0.000829	CbGpPWpGaD
Oxazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000381	0.000818	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000379	0.000814	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000374	0.000803	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00036	0.000772	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000358	0.000768	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000355	0.000761	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000353	0.000758	CbGpPWpGaD
Oxazepam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000347	0.000745	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000344	0.000739	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000327	0.000703	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000323	0.000694	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000313	0.000672	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000306	0.000657	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000298	0.000641	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000295	0.000634	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000294	0.000632	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000292	0.000626	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000292	0.000626	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000289	0.000621	CbGpPWpGaD
Oxazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000281	0.000603	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00028	0.000602	CbGpPWpGaD
Oxazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.000595	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000274	0.000589	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GC—chronic obstructive pulmonary disease	0.000273	0.000586	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000272	0.000584	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00027	0.000581	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00026	0.000558	CbGpPWpGaD
Oxazepam—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000258	0.000554	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000256	0.00055	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000254	0.000544	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000253	0.000543	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00025	0.000537	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000245	0.000527	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000244	0.000524	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00024	0.000516	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000237	0.000508	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000234	0.000502	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000228	0.00049	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000228	0.000489	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000227	0.000488	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000227	0.000487	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.000485	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000224	0.000481	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000224	0.00048	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	0.000222	0.000476	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000221	0.000475	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.000451	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.00021	0.00045	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	0.000209	0.000449	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000208	0.000447	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000206	0.000442	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000202	0.000434	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.0002	0.00043	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000198	0.000425	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000198	0.000425	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000198	0.000424	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000196	0.000422	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000193	0.000414	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000192	0.000411	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00019	0.000407	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000188	0.000404	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	0.000186	0.0004	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000185	0.000397	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000184	0.000394	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000175	0.000376	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000175	0.000376	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000175	0.000376	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000173	0.000372	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000173	0.000371	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.00017	0.000364	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.000357	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000164	0.000353	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.000352	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000162	0.000347	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000161	0.000346	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.000328	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000149	0.00032	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000147	0.000316	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000144	0.00031	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000142	0.000305	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000139	0.000298	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000139	0.000297	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000137	0.000294	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000137	0.000294	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	0.000135	0.000289	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000134	0.000289	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000134	0.000289	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ALB—chronic obstructive pulmonary disease	0.000134	0.000288	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000133	0.000285	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000128	0.000276	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000127	0.000274	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000126	0.00027	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000125	0.000269	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.000266	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000121	0.000261	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000121	0.00026	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.000259	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00012	0.000257	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.000256	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000118	0.000253	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000116	0.000249	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000114	0.000244	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000113	0.000243	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000112	0.00024	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000111	0.000238	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000109	0.000235	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ALB—chronic obstructive pulmonary disease	0.000104	0.000223	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000103	0.000222	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000102	0.000219	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000102	0.000219	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000101	0.000216	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.000216	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—NOS3—chronic obstructive pulmonary disease	9.93e-05	0.000213	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	9.72e-05	0.000209	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.7e-05	0.000208	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.49e-05	0.000204	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	9.18e-05	0.000197	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9e-05	0.000193	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.46e-05	0.000182	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.39e-05	0.00018	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.28e-05	0.000178	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.71e-05	0.000166	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.36e-05	0.000158	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.31e-05	0.000157	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	7.28e-05	0.000156	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.06e-05	0.000152	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.96e-05	0.000149	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	6.64e-05	0.000143	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.49e-05	0.000139	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.44e-05	0.000138	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.26e-05	0.000135	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.15e-05	0.000132	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.12e-05	0.000131	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	6.12e-05	0.000131	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	5.85e-05	0.000126	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.82e-05	0.000125	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.1e-05	0.00011	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.03e-05	0.000108	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	4.97e-05	0.000107	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.75e-05	0.000102	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.69e-05	0.000101	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.44e-05	9.54e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	4.18e-05	8.98e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	4e-05	8.59e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.42e-05	7.35e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.38e-05	7.26e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.09e-05	6.63e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	3.02e-05	6.49e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	2.89e-05	6.21e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.84e-05	6.11e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.37e-05	5.09e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.34e-05	5.02e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.18e-05	4.68e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.07e-05	4.44e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.4e-05	3.02e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.34e-05	2.89e-05	CbGpPWpGaD
